Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells
about
NEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV targetKaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latencyNEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process.Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression.Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neuronsSystemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivoInhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial CellsIdentification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANAKaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cellsThe inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cellsReview of latent and lytic phase biomarkers in Kaposi's sarcoma.The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.Utilising proteomic approaches to understand oncogenic human herpesviruses (Review).Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65.Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.Kaposi sarcoma herpesvirus pathogenesis.microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.Generation of a KSHV K13 deletion mutant for vFLIP function study.The interferon-stimulated gene product oligoadenylate synthetase-like protein enhances replication of Kaposi's sarcoma-associated herpesvirus (KSHV) and interacts with the KSHV ORF20 protein.VEGF Upregulation in Viral Infections and Its Possible Therapeutic Implications.Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication
P2860
Q28544735-D8484A07-8585-4ACF-A59C-633C6A86FB73Q33632932-C7A52EB4-521F-4EA7-936F-A0DD2EF4E523Q33887749-779BFE4A-F61D-407F-8E29-E3374EE2BCF1Q34426472-D1655366-F099-45CA-9133-9722225D5B26Q35133263-EA5B8D70-D8D4-4736-9E64-9A612B51C320Q35546590-4D9C4F33-A2D6-4FBF-8A92-146E0FAFD0CFQ35752316-4D3DDDC8-0C49-44AD-964E-ED26E434F7C4Q35943531-84321AF6-512C-483B-B2C9-8416A96F45EBQ36155542-12CA1FA6-E94B-4675-9154-93B80612BDC8Q36911706-F8BCEB26-53EF-4DD5-8EB8-AC0F8BF2887DQ37088335-946B70E2-757D-43BD-965B-D4241B018C9AQ37288834-E4197259-2820-4BA0-B2F3-CE7E1210D1F0Q38144129-80ACC916-5B6C-48F5-B89D-8DF27B583B5FQ38248404-E19F8C14-70BB-42D8-A447-C6A585127062Q38256387-494D6A78-3057-4003-8476-A5871A0F1288Q38959978-7B365470-E04F-4A08-AC79-6E678191D7DAQ39792755-07A71E82-6E64-4051-99CC-DA49E56A98DEQ40046587-79A11367-3B58-4D83-9B29-093AC09B8900Q40120040-7EAFDE5C-091A-4F00-BE29-A03B3885B068Q41932132-186D5252-2C50-42D2-83A7-2BCA99072792Q47290411-E250EA9A-D821-41F7-991F-1916BE9730D1Q52803195-9D032144-3010-4820-8705-67A0C478A0E2Q55618701-C4A3EA43-22D9-4E27-ABE2-3D3BBDEA4538Q57169056-B50DD03F-DD27-40E4-B621-79949F503FD8
P2860
Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Deletion of Kaposi's sarcoma-a ...... formation in endothelial cells
@en
type
label
Deletion of Kaposi's sarcoma-a ...... formation in endothelial cells
@en
prefLabel
Deletion of Kaposi's sarcoma-a ...... formation in endothelial cells
@en
P2093
P2860
P50
P356
P1433
P1476
Deletion of Kaposi's sarcoma-a ...... formation in endothelial cells
@en
P2093
Andreas Konrad
Dagmar Wirth
Oliver Dittrich-Breiholz
Raffaella Bosco
Susann Santag
Thomas F Schulz
Vivek Vikram Singh
P2860
P304
10375-10388
P356
10.1128/JVI.00226-11
P407
P577
2011-07-27T00:00:00Z